HIF1A and triple-negative breast carcinoma: Similarly, in triple-negative breast cancer, increased activity of the HIF1 pathway was detected [142], and collagen prolyl 4-hydroxylase 1 (P4HA1) was demonstrated to enhance HIF1α stability by modulating α-ketoglutarate and succinate levels.